Evaluation of the fracture risk assessment tool for determining bone disease and the impact of secondary causes of osteoporosis in people living with HIV

References

• Young B, Dao CN, Buchacz K, Baker R, Brooks JT, the HIV Outpatient Study (HOPS) Investigators. Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000–2006. Clin Infect Dis. 2011;52(8):1061–1068.
   PubMed Web of Science ®Google Scholar
• Peters BS, Perry M, Wierzbicki AS, et al. A cross-sectional randomised study of fracture risk in people with HIV infection in the probono 1 study. PLoS One. 2013;8(10):e78048.
   PubMed Web of Science ®Google Scholar
• Gonciulea A, Wang R, Althoff KN, et al. An increased rate of fracture occurs a decade earlier in HIV + compared with HIV-men. Aids. 2017;31(10):1435–1443.
   PubMed Web of Science ®Google Scholar
• Battalora L, Buchacz K, Armon C, et al.; the HIV Outpatient Study (HOPS) and SUN Study Investigators. Low bone mineral density and risk of incident fracture in HIV-infected adults. Antivir Ther. 2015;21(1):45–54.
   Web of Science ®Google Scholar
• European AIDS Clinical Society. European AIDS Clinical Society Guidelines Version 9.1 2018.
   Google Scholar
• Martínez E, Jódar Gimeno E, Reyes García R, et al.; Sociedad Española de Fractura Osteoporótica. [Consensus statement: recommendations for the management of metabolic bone disease in human immunodeficiency virus patients]. Enferm Infecc Microbiol Clin. 2014;32(4):250–258.
   Web of Science ®Google Scholar
• Crespo M, Curran A, García F, et al. Documento de consenso de GESIDA sobre control y monitorización de la infección por el VIH Coordinadores. 2018.
   Google Scholar
• Negredo E, Domingo P, Gutiérrez F, et al. Executive summary of the consensus document on osteoporosis in HIV-infected individuals. Enferm Infecc Microbiol Clin. 2018;36(5):312–314.
   Web of Science ®Google Scholar
• Kanis JA, Hans D, Cooper C, Task Force of the FRAX Initiative, et al. Interpretation and use of FRAX in clinical practice. Osteoporos Int. 2011;22(9):2395–2411.
   PubMed Web of Science ®Google Scholar
• Calmy A, Fux CA, Norris R, et al. Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross‐sectional study. J Infect Dis. 2009;200(11):1746–1754.
   PubMed Web of Science ®Google Scholar
• Pepe J, Isidori AM, Falciano M, et al. The combination of FRAX and Ageing Male Symptoms scale better identifies treated HIV males at risk for major fracture. Clin Endocrinol (Oxf). 2012;77(5):672–678.
   PubMed Web of Science ®Google Scholar
• Yin MT, Shiau S, Rimland D, et al. Fracture prediction with modified-FRAX in older HIV-infected and uninfected men. JAIDS J Acquir Immune Defic Syndr 2016;72:1.
   Web of Science ®Google Scholar
• Short CS, Shaw SG, Fisher MJ, Gilleece YC, Walker-Bone K. Comparison of peripheral forearm DXA and clinical risk factor screening using FRAX® to assess the risk of HIV-associated low bone mass: a cross-sectional study. Arch Osteoporos. 2014;9(1):181.
   Web of Science ®Google Scholar
• Gazzola L, Comi L, Savoldi A, et al. Use of the FRAX equation as first-line screening of bone metabolism alteration in the HIV-infected population. J Infect Dis. 2010;202(2):330.
   Web of Science ®Google Scholar
• Mazzotta E, Ursini T, Agostinone A, et al. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management. AIDS Patient Care Stds. 2015;29(4):169–180.
   Web of Science ®Google Scholar
• Stephens KI, Rubinsztain L, Payan J, Rentsch C, Rimland D, Tangpricha V. Dual-energy X-ray absorptiometry and calculated frax risk scores may underestimate osteoporotic fracture risk in vitamin d-deficient veterans with HIV infection. Endocr Pract. 2016;22(4):440–446.
   Web of Science ®Google Scholar
• Llop M, Sifuentes WA, Bañón S, et al. Increased prevalence of asymptomatic vertebral fractures in HIV-infected patients over 50 years of age. Arch Osteoporos. 2018;13(1):56.
   Web of Science ®Google Scholar
• Lujan-Barroso L, Gibert K, Obón-Santacana M, et al. The influence of lifestyle, diet, and reproductive history on age at natural menopause in Spain: analysis from the EPIC-Spain sub-cohort. Am J Hum Biol. 2018;30(6):e23181.
   Web of Science ®Google Scholar
• Crum NF, Furtek KJ, Olson PE, Amling CL, Wallace MR. A review of hypogonadism and erectile dysfunction among HIV-infected men during the Pre- and Post-HAART eras: diagnosis, pathogenesis, and management. AIDS Patient Care Stds. 2005;19(10):655–671.
   Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, Zhang YL, et al.; for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
   PubMed Web of Science ®Google Scholar
• Lin J-C, Hsieh T-Y, Wu C-C, et al. Association between Chronic Hepatitis C Virus Infection and Bone Mineral Density. Calcif Tissue Int. 2012;91(6):423–429.
   Web of Science ®Google Scholar
• International Society for Clinical Densitometry. 2019 ISCD Official Positions—Adult. 2019.
   Google Scholar
• Kanis JA, Oden A, Johansson H, Borgström F, Ström O, McCloskey E. FRAX and its applications to clinical practice. Bone 2009;44(5):734–743.
   PubMed Web of Science ®Google Scholar
• Casado JL. Renal and bone toxicity with the use of tenofovir: understanding at the end. AIDS Rev. 2016;18(2):59–68.
   PubMed Web of Science ®Google Scholar
• Bañón S, Rosillo M, Gómez A, Pérez-Elias MJ, Moreno S, Casado JL. Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients. Endocrine 2015;49(2):528–537.
   Web of Science ®Google Scholar
• Bonjoch A, Figueras M, Estany C, et al. High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study. AIDS 2010;24:2827–2833.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18(8):1033–1046.
   PubMed Web of Science ®Google Scholar